| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Neurosurgical [L. B. J., K. P., R. L. M.] and Neurology Services [G. A. R.], Massachusetts General Hospital, and Departments of Surgery [L. B. J., R. L. M.] and Genetics [G. A. R.], Harvard Medical School, Boston, Massachusetts 02114
Meningiomas and schwannomas are two of the most common tumors of the human nervous system. To determine whether these tumors arise from a single cell or from multiple cells, we used molecular genetic techniques to study X chromosome inactivation in meningiomas and schwannomas isolated from females including one who had neurofibromatosis type 2. The tumors were also screened for loss of heterozygosity at several loci on chromosome 22 using polymorphic DNA markers. Among nine meningiomas, at least three of which showed loss of alleles on chromosome 22 and five of which retained heterozygosity for the chromosome 22 alleles examined, all nine tumors were monoclonal. Among eight schwannomas, at least seven of which retained heterozygosity for chromosome 22 loci, seven were monoclonal. We conclude that human meningiomas and schwannomas arise from a single cell.
1 This work was supported by USPHS grants NS20025 and NS24219, the National Neurofibromatosis Foundation, and Neurofibromatosis, Inc. (Massachusetts Bay Area).
2 To whom requests for reprints should be addressed, at Molecular Neurogenetics Laboratory, Massachusetts General Hospital-East, 149 13th Street, Charlestown, MA 02129.
Received 4/12/90. Accepted 7/23/90.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |